Loperamide Hydrochloride
NDC 67296-0129
Product Information
Loperamide Hydrochloride is a ANDA-approved product labeled by Redpharm Drug, Inc.. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a brown product. This product entry covers the primary NDC 67296-0129 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
MYLAN;2100
Code Structure Chart
Product Details
What is NDC 67296-0129?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- LOPERAMIDE HYDROCHLORIDE (UNII: 77TI35393C)
- LOPERAMIDE (UNII: 6X9OC3H4II) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- FERROSOFERRIC OXIDE (UNII: XM0M87F357)
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- SHELLAC (UNII: 46N107B71O)
- GELATIN (UNII: 2G86QN327L)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- FERRIC OXIDE RED (UNII: 1K09F3G675)
- SODIUM LAURYL SULFATE (UNII: 368GB5141J)
- SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
- D&C YELLOW NO. 10 (UNII: 35SW5USQ3G)
- FD&C BLUE NO. 1 (UNII: H3R47K3TBD)
- FD&C BLUE NO. 2 (UNII: L06K8R7DQK)
- FD&C RED NO. 40 (UNII: WZB9127XOA)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 978006 - loperamide HCl 2 MG Oral Capsule
- RxCUI: 978006 - loperamide hydrochloride 2 MG Oral Capsule
* Please review the full disclaimer at the bottom of this page.